NASDAQ · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · SMALL CAP
Sanara Medtech Inc. SMTI
16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$103.1M
▲ 19.0% vs FY2024
EPS · FY25
$-4.36
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-165.7%
Net margin · FY25
-36.4%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 103.1M
Revenue, FY2025 · full 16-year series below
Revenue
Net income
The company lost 36 cents on every revenue dollar this year.
Per share
USD -4.36
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-165.7%
Return on equity, FY2025
ROE
Operating margin7.1%
Net margin-36.4%
Return on assets-46.7%
Each USD of equity lost 166 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+45.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+31.0%
+45.9%
+40.8%
+37.1%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years+42.1%
Change, 10 years—
The share count grew 42% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 72.9M
total assets, end of FY2025
Total assetsUSD 72.9M
EquityUSD 5.9M
CashUSD 16.6M
Gross debtUSD 46.0M
Net debtUSD 29.4M
Current ratio1.80×
Net debt stands at 495% of equity.
History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
·
·
−0.0
−0.0
−0.0
EBITDA $B
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
·
·
·
·
·
·
−0.0
−0.0
−0.0
Income tax $B
·
0.0
·
−0.0
·
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−4.36
−1.14
−0.52
−1.00
−1.08
−0.76
−1.32
0.00
0.00
−0.01
−0.02
−0.03
−0.05
−0.03
−0.23
−0.19
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−165.7
−22.9
−9.9
−21.9
−43.1
−69.6
−78.2
−174.2
·
·
·
·
·
·
·
−1190.7
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.11
0.11
0.11
0.09
0.09
0.07
0.06
0.04
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
62 of 62
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed